Safety and Efficacy of HMI-103 in Participants With Classical PKU Due to PAH Deficiency

NCT05222178 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Homology Medicines Inc. has discontinued the development of this program.

Conditions

Phenylketonurias
PAH Deficiency
Phenylketonuria

Interventions

DRUG: HMI-103

Sponsor

Homology Medicines, Inc